Moderate dose melatonin for the abatement and treatment of delirium in elderly general medical inpatients: study protocol of a placebo controlled, randomised, double blind trial

BACKGROUND: Delirium is a frequent, costly and morbid problem. No agent has been shown to modify the natural history of the condition, and current treatments have significant side effects. Prophylactic melatonin in low doses has been shown to prevent delirium developing. This trial then aims to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Clayton-Chubb, Daniel I., Lange, Peter W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772311/
https://www.ncbi.nlm.nih.gov/pubmed/26928392
http://dx.doi.org/10.1186/s12877-016-0230-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772311/
https://www.ncbi.nlm.nih.gov/pubmed/26928392
http://dx.doi.org/10.1186/s12877-016-0230-5

Ejemplares similares